ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

EOLS Evolus Inc

11,33
-0,255 (-2,20%)
15 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Evolus Inc EOLS NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,255 -2,20% 11,33 01:00:09
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
11,48 11,23 11,55 11,33 11,585
mais cotações »

Notícias Recentes

Data Hora Fonte Título
12/06/202409:00BWEvolus Broadens International Presence with Launch of..
07/06/202418:00BWEvolus Reports Inducement Grants Under Nasdaq Listing Rule..
20/05/202409:30BWEvolus Announces Positive Data from Pivotal Trial for First..
15/05/202409:30BWEvolus Celebrates Fifth Anniversary of Launching its..
10/05/202419:55BWEvolus Reports Inducement Grants Under Nasdaq Listing Rule..
10/05/202410:10BWEvolus’ Sandra Beaver Named Orange County Business Journal’s..
07/05/202417:05BWEvolus Reports First Quarter 2024 Results and Provides..
23/04/202417:30BWEvolus to Report First Quarter Financial Results on May 7,..
17/04/202417:05BWEvolus Announces Publication of Safety and Duration Data..
12/04/202417:05BWEvolus Reports Inducement Grants Under Nasdaq Listing Rule..
26/03/202409:00BWEvolus to Participate in the 23rd Annual Needham Virtual..
11/03/202408:00BWEvolus Announces Pricing of $50.0 Million Underwritten..
08/03/202418:05BWEvolus Reports Inducement Grants Under Nasdaq Listing Rule..
07/03/202418:05BWEvolus Reports Record Fourth Quarter and Full Year 2023..
01/03/202410:30BWEvolus Announces Results from European Head-to-Head Filler..
27/02/202410:30BWEvolus to Participate in Upcoming Leerink Partners and..
22/02/202418:30BWEvolus to Report Fourth Quarter and Year End 2023 Results..
09/02/202418:05BWEvolus Reports Inducement Grants Under Nasdaq Listing Rule..
16/01/202419:28BWEvolus Announces Preliminary Unaudited Fourth Quarter and..
12/01/202418:23BWEvolus Reports Inducement Grants Under Nasdaq Listing Rule..
11/01/202408:18IHMARKETNEWSWall Street Highlights: Mastercard’s Financial Rise,..
04/01/202418:05BWEvolus Announces the Appointment of Nareg Sagherian to Vice..
20/12/202310:00BWEvolus Enters into Licensing Agreement with Symatese to..
12/12/202307:50IHMARKETNEWSHasbro Job Cuts, Oracle’s Stock Decline, Google’s Epic..
08/12/202318:30BWEvolus Reports Inducement Grants Under Nasdaq Listing Rule..
10/11/202319:16BWEvolus Reports Inducement Grants Under Nasdaq Listing Rule..
07/11/202318:16BWEvolus Reports Record Third Quarter 2023 Financial Results..
06/11/202310:45BW“Extra-Strength” 40U Formulation of Jeuveau® Demonstrates..
01/11/202309:45BWEvolus to Participate in November Investor Conferences
25/10/202309:45BWFinal Phase 2 Data Evaluating 40U Dose of..
29/09/202317:05BWEvolus Reports Inducement Grants Under Nasdaq Listing Rule..
29/08/202309:45BWEvolus to Participate in September Conferences
23/08/202319:53BWEvolus Announces Inducement Grants for New Chief Marketing..
21/08/202309:45BWEvolus Appoints Tomoko Yamagishi-Dressler as Chief Marketing..
08/08/202309:45BWEvolus Unveils New Branding for Flagship Product Jeuveau® to..
02/08/202317:05BWEvolus Reports Second Quarter 2023 Results and Provides..
27/07/202309:45BWEvolus Raises Full-Year Revenue Guidance on Record Second..
26/07/202309:45BWEvolus to Participate in Canaccord Genuity’s 43rd Annual..
19/07/202309:45BWEvolus to Report Second Quarter 2023 Results and Provide..
29/06/202310:00BWEvolus Launches Nuceiva® (botulinum toxin type A) in Italy
22/06/202309:45BWEvolus Announces Successful Completion of Phase 2 Study..

Seu Histórico Recente